Why is Fredun Pharma falling/rising?

As of 12-Sep, Fredun Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 1,214.00, reflecting a decrease of 16.0 points or 1.3%. The stock has been underperforming recently, having fallen for the last four consecutive days, resulting in an overall drop of 8.4% during this period. Despite opening with a gain of 3.09% today and reaching an intraday high of Rs 1268, it ultimately closed lower. The stock's performance over the past week shows a decline of 6.25%, while it has still managed to deliver a strong return of 64.67% year-to-date. However, the recent drop in delivery volume by nearly 60% suggests a falling investor participation, which may be contributing to the downward price movement.
In the broader market context, the Sensex has shown a positive return of 1.48% over the past week, contrasting with Fredun's decline, indicating that the stock is lagging behind the benchmark. Although the company has demonstrated healthy long-term growth with significant increases in net sales and operating profit, the lack of domestic mutual fund investment may signal caution among institutional investors. This could be impacting market sentiment negatively, despite the stock's impressive year-on-year return of 53.09% against a backdrop of negative returns in the broader market. The attractive valuation metrics and consistent positive quarterly results highlight the company's potential, but the recent performance suggests that investor confidence may be wavering.